Quality Stocks That Beat Index (1W)
Review premium stocks that beat benchmarks this week, offering consistent returns and stability.
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$898.4B | 7.1 | $91.4 52.2% overvalued | 52.1% | $54.5B | $20.7B | 40.3% | 38.0% | 63.3% | 9.9% | 95.4% | |
$40.5B | 7.0 | $42.8 92.0% overvalued | 74.2% | $2,084.3M | $329.5M | 33.3% | 15.8% | 59.5% | 2.7% | 31.0% | |
$18.8B | 6.9 | $18.4 11.4% overvalued | 37.0% | $9,702.3M | $1,243.7M | 14.4% | 12.8% | 43.5% | 42.0% | 54.9% | |
$10.4B | 7.1 | $18.9 79.5% overvalued | 45.5% | $935.8M | $109.5M | 28.5% | 11.7% | 56.6% | 66.1% | 19.5% | |
$10.0B | 6.9 | $110.4 27.7% undervalued | 91.9% | $9,635.6M | $335.5M | 20.1% | 3.5% | 10.5% | 13.5% | 134.5% | |
$8,088.2M | 6.7 | $231.1 3.3% undervalued | 10.6% | $3,122.6M | $314.2M | 14.8% | 10.1% | 12.3% | 28.8% | 0.3% | |
$7,718.1M | 7.4 | $7.0 43.0% overvalued | 56.8% | ZAR 104.0B | ZAR 11.7B | 53.1% | 11.3% | 27.7% | 42.6% | 5.6% | |
$4,538.3M | 6.8 | $20.0 29.5% overvalued | 106.7% | $1,897.1M | $233.5M | (17.3%) | 12.3% | 64.9% | 5.8% | 98.8% | |
$4,324.6M | 6.8 | $36.4 55.6% overvalued | (1.0%) | $2,539.8M | $97.1M | 4.8% | 3.8% | 24.2% | 16.3% | 38.5% | |
$4,191.3M | 7.0 | $27.4 45.4% undervalued | (8.8%) | CN¥7,112.3M | CN¥2,557.7M | 30.4% | 36.0% | 83.1% | 32.6% | 2.5% | |
$4,112.3M | 6.9 | $19.0 27.7% overvalued | 71.4% | $1,362.6M | $170.5M | 11.9% | 12.5% | 34.9% | 14.1% | 53.8% | |
$3,837.5M | 6.8 | $19.8 22.7% overvalued | 106.0% | ARS 926.4B | ARS 130.1B | 333.5% | 14.0% | 48.0% | 12.0% | 28.7% | |
$3,644.7M | 6.6 | $20.1 31.1% overvalued | 17.5% | $871.7M | $44.8M | 41.9% | 5.1% | 26.9% | 15.4% | 1.7% | |
$3,609.2M | 6.8 | $18.0 26.6% undervalued | (15.8%) | $1,108.8M | $46.4M | 35.8% | 4.2% | 28.8% | 14.0% | 7.4% | |
$2,007.9M | 7.1 | $221.2 32.7% undervalued | (1.1%) | $1,059.8M | $48.9M | 38.3% | 4.6% | 26.8% | 38.0% | 0.3% | |
$1,963.7M | 6.5 | $24.2 29.8% overvalued | 35.2% | $516.0M | $41.9M | 4.5% | 8.1% | 38.5% | 47.2% | 0.2% | |
$1,362.7M | 7.4 | $135.2 29.5% undervalued | 23.2% | $245.0M | $248.5M | (20.2%) | 101.4% | 90.9% | 73.6% | 2.6% | |
$893.8M | 7.4 | $50.6 74.2% undervalued | 122.8% | $435.4M | $91.7M | 11.0% | 21.1% | 40.9% | 7.3% | 62.5% | |
$560.1M | 6.7 | $34.2 14.4% overvalued | 48.6% | $565.8M | $63.7M | 10.9% | 11.3% | 33.9% | 9.9% | 46.0% |
Improve returns with AI recommendations
Keep track of upcoming earnings reports from top companies
UNH
Last Price
481.52
0.1%Market Cap
$446.4B
6
total score
33.6%
undervalued
ORCL
Last Price
147.66
(2.1%)Market Cap
$425.0B
6
total score
24.8%
undervalued
JNJ
Last Price
162.99
0.1%Market Cap
$392.3B
6
total score
20.8%
undervalued
ABBV
Last Price
211.55
(0.2%)Market Cap
$373.4B
6
total score
42.5%
undervalued
CSCO
Last Price
59.67
(1.3%)Market Cap
$237.5B
6
total score
28.2%
undervalued
ABT
Last Price
129.89
(0.3%)Market Cap
$224.9B
7
total score
44.5%
undervalued
Explore more stock ideas
Top Weekly Performers
Explore the top weekly stock winners for 18 Mar 2025, outperforming the market and delivering gains.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Magnificent 7 stocks
Discover the Magnificent 7 stocks—market leaders with stellar performance. Learn what they are and track their latest metrics.
3M Return 25.6%
S&P Outperformance 12.6%
Next 3M Predicted Return 30.3%